ArticleBlood2023
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients.
Open access · bronzeAbstract read
In one paragraph
Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 22 citations in OpenAlex.
- Article
- Literature review of pediatric Erdheim-Chester disease (ECD) and mixed histiocytosis (Langerhans cell histiocytosis/ECD).Annals of translational medicine · 2026Review
- Kidney Transplantation in Patients With Erdheim-Chester Disease.Kidney international reports · 2026Article
- Clinical spectrum of pediatric-onset Erdheim-Chester disease: insights from a single-center case series.Frontiers in pediatrics · 2026Article
- Case Report: Pediatric Erdheim-Chester disease with bilateral chorioretinal and central nervous system infiltration.Frontiers in medicine · 2026Article
- The xanthogranuloma family of histiocytic neoplasms in the molecular era: Erdheim-Chester disease and beyond.Hematology. American Society of Hematology. Education Program · 2025Review
- Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration.Haematologica · 2025Review
- Efficacy and safety of Dabrafenib in Erdheim-Chester disease.Annals of hematology · 2025Article
- Unraveling the molecular landscape of Erdheim-Chester disease: new insights from methylome and transcriptome integration.Leukemia · 2025Article
- MEK inhibitors are effective in Erdheim-Chester disease regardless of MAPK pathway mutations.Leukemia · 2025Article
- Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study.Blood advances · 2025Article
- IgG4-related disease and other fibro-inflammatory conditions.Nature reviews. Rheumatology · 2025Review
- Updates on Langerhans cell histiocytosis and other histiocytosis in children: invited review-challenges and novelties in paediatric tumours.Virchows Archiv : an international journal of pathology · 2025Review
- Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.Blood neoplasia · 2024Article
- Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis).EClinicalMedicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 12 institutions in 7 countries.
Francesco PegoraroDepartment of Health Sciences, University of Florence, Florence, Italy.ORCID 0000-0002-4954-5744
Martina MazzariolDepartment of Medical Sciences, University of Turin, Turin, Italy.
Irene TrambustiHematology and Oncology Unit, Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Florence, Italy.ORCID 0000-0001-8106-8098
Sameer BakhshiDepartment of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Saumyaranjan MallickDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0003-4366-5873
Ira J DunkelDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-8091-6067
Cor van den BosDepartment of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Özlem TezolDepartment of Pediatrics, Mersin University Faculty of Medicine, Mersin, Turkey.
Shijun ShanDepartment of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China.
Suheyla OcakDepartment of Pediatric Hematology-Oncology, Istanbul University Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0001-7479-7444
Flavio GiordanoDepartment of Neurosurgery, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID 0000-0002-9006-9225
Carmela De FuscoDepartment of Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono-Pausilipon, Pausilipon Hospital, Naples, Italy.
Stefania GaspariDepartment of Pediatric Hematology/Oncology, Cellular and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Anna Maria BuccolieroPathology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Maria Luisa ConiglioHematology and Oncology Unit, Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Florence, Italy.
Elisa ButiNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Paola RomagnaniNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Jennifer PicarsicCincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH.ORCID 0000-0002-3718-6422
Jean DonadieuPediatric Oncology and Hematology, Armand-Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, EA4340-BECCOH, Referral Center for Histiocytoses Université de Versailles Saint-Quentin-en-Yvelines, Paris, France.ORCID 0000-0002-4485-146X
Eli L DiamondDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-5456-5961
Jean-François EmileEA4340 BECCOH, Université de Versailles Saint-Quentin-en-Yvelines, Service de Pathologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France.ORCID 0000-0002-6073-4466
Elena SieniHematology and Oncology Unit, Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Florence, Italy.ORCID 0000-0002-6192-9812
Julien HarocheDepartment of Internal Medicine, Institut E3M French Reference Centre for Histiocytosis, Pitié-Salpȇtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
Augusto VaglioNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Meyer Children's Hospital · ITAll India Institute of Medical Sciences · INMemorial Sloan Kettering Cancer Center · USUniversité de Versailles Saint-Quentin-en-Yvelines · FRBambino Gesù Children's Hospital · ITChina Medical University · CNCincinnati Children's Hospital Medical Center · USIstanbul University-Cerrahpaşa · TRMersin Üniversitesi · TRPrincess Máxima Center · NLSorbonne Université · FRUniversity of Pisa · IT
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MMolecular Pathogenesis and Therapy of Systemic Histiocytic NeoplasmsR37CA259260 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Eli Lous Diamond · 2021 to 2026
$3.3MNCI NIH HHS P30 CA008748NCI NIH HHS R37 CA259260
Abstract
PubMed holds no abstract for this paper.
Indexed as
Erdheim-Chester DiseaseChildHumansPhenotype
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.